{{Rsnum
|rsid=2290732
|Gene=GABRA1
|Chromosome=5
|position=161897892
|Orientation=plus
|GMAF=0.4366
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=GABRA1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 14.3 | 42.9 | 42.9
| HCB | 33.6 | 43.1 | 23.4
| JPT | 22.1 | 48.7 | 29.2
| YRI | 17.9 | 49.0 | 33.1
| ASW | 14.3 | 48.2 | 37.5
| CHB | 33.6 | 43.1 | 23.4
| CHD | 24.1 | 60.2 | 15.7
| GIH | 14.0 | 50.0 | 36.0
| LWK | 14.7 | 53.2 | 32.1
| MEX | 17.2 | 55.2 | 27.6
| MKK | 14.6 | 49.7 | 35.8
| TSI | 16.7 | 52.9 | 30.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=20404824
|Title=Imprinting in the schizophrenia candidate gene GABRB2 encoding GABA(A) receptor beta(2) subunit
}}

{{PMID Auto
|PMID=24482035
|Title=Benzodiazepine-Associated Hepatic Encephalopathy Significantly Increased Healthcare Utilization and Medical Costs of Chinese Cirrhotic Patients: 7-Year Experience
}}

{{PMID Auto
|PMID=22591328
|Title=Effects of SCN1A and GABA receptor genetic polymorphisms on carbamazepine tolerability and efficacy in Chinese patients with partial seizures: 2-year longitudinal clinical follow-up.
}}

{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}